Author/Creator: Pender, Alexandra - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Pender, Alexandra

1. Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world. (16th November 2021)

Authors:: Shokoohi, Aria; Al‐Hashami, Zamzam; Moore, Sara; Pender, Alexandra; Wong, Selina K.; Wang, Ying; Leung, Bonnie; Wu, Jonn; Ho, Cheryl
Journal:: Cancer medicine
Issue:: Volume 11:Number 1(2022)
Page Start:: 86
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype. Issue 3 (23rd December 2019)

Authors:: Naso, Julia R; Wang, Gang; Pender, Alexandra; Wong, Selina K; Zhu, Jingyao; Ho, Cheryl; Ionescu, Diana N; Zhou, Chen
Journal:: Histopathology
Issue:: Volume 76:Issue 3(2020)
Page Start:: 394
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience. (June 2021)

Authors:: Khalique, Saira; Lubel, Jessica; Docherty, Catherine; Kanu, Abimbola; Etessami, Nazanin; MacMahon, Suzanne; Peters, Natalie; Pender, Alexandra; Patel, Anant; Boleti, Ekaterini
Journal:: Lung cancer
Issue:: Volume 156(2021)Supplement 1
Page Start:: S38
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Olaratumab for the treatment of soft-tissue sarcoma. (October 2017)

Authors:: Pender, Alexandra; Jones, Robin L
Journal:: Future oncology
Issue:: Volume 13:Number 24(2017)
Page Start:: 2151
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer. (June 2015)

Authors:: Pender, Alexandra; Popat, Sanjay
Journal:: Therapeutic advances in respiratory disease
Issue:: Volume 9:Number 3(2015:Jun.)
Page Start:: 97
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Understanding lung cancer molecular subtypes. (July 2014)

Authors:: Pender, Alexandra; Popat, Sanjay
Journal:: Clinical practice
Issue:: Volume 11:Number 4(2014)
Page Start:: 441
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Uptake of second-line anticancer therapy after first-line pembrolizumab in patients with stage IV non–small cell lung cancer with PD-L1 > 50%: Comparison between clinical trials and the real world. Issue 28 (1st October 2022)

Authors:: Rittberg, Rebekah; Jones, Lauren; Leung, Bonnie; Shokoohi, Aria; Ionescu, D N; Pender, Alexandra; Yuan, Ren; Wong, Selina K.; Al-Hashami, Zamzam Salam; Wang, Ying; Ho, Cheryl
Journal:: Journal of clinical oncology
Issue:: Volume 40:Issue 28(2022)Supplement
Page Start:: 126
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗